The cystic fibrosis foundation therapeutics development network: A national effort by the cystic fibrosis foundation to build a clinical trials network

被引:4
作者
Goss, Christopher H. [1 ,2 ]
Mayer-Hamblett, Nicole [1 ,2 ]
Williams, Judy [2 ]
Ramsey, Bonnie W. [1 ,2 ]
机构
[1] Univ Washington, Med Ctr, Sch Med, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Cystic Fibrosis Therapeut Dev Network, Coordinating Ctr, Seattle, WA 98105 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1080/02739610701766859
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Clinical trial networks that provide centralized coordination of multicenter studies have become critical to the advancement of clinical research. We describe a national effort by the U.S. Cystic Fibrosis Foundation (CFF) to build a network to evaluate therapeutic interventions in cystic fibrosis (CF). The CFF Therapeutics Development Network (CFF TDN) was established in 1998 and has since promoted the safe and efficient conduct of multiple clinical trials. The orphan disease setting presents many challenges for clinical research, and the CFF TDN has met these challenges by advancing CF outcome measures development and fostering innovative approaches toward the design and analysis of clinical trials.
引用
收藏
页码:5 / 20
页数:16
相关论文
共 51 条
  • [1] Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis
    Ahrens, RC
    Standaert, TA
    Launspach, J
    Han, SH
    Teresi, ME
    Aitken, ML
    Kelley, TJ
    Hilliard, KA
    Milgram, LJH
    Konstan, MW
    Weatherly, MR
    McCarty, NA
    [J]. PEDIATRIC PULMONOLOGY, 2002, 33 (02) : 142 - 150
  • [2] Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.3.CO
  • [3] 2-G
  • [4] Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients
    Borowitz, Drucy
    Goss, Christopher H.
    Stevens, Christopher
    Hayes, Denise
    Newman, Laurie
    O'Rourke, Anna
    Konstan, Michael W.
    Wagener, Jeffrey
    Moss, Richard
    Hendeles, Leslie
    Orenstein, David
    Ahrens, Richard
    Oermann, Christopher M.
    Aitken, Moira L.
    Mahl, Thomas C.
    Young, K. Randall, Jr.
    Dunitz, Jordan
    Murray, Frederick T.
    [J]. PANCREAS, 2006, 32 (03) : 258 - 263
  • [5] A multicenter study of the effect of solution temperature on nasal potential difference measurements
    Boyle, MP
    Diener-West, M
    Milgram, L
    Knowles, M
    Foy, C
    Zeitlin, P
    Standaert, T
    [J]. CHEST, 2003, 124 (02) : 482 - 489
  • [6] Using the ROC curve for gauging treatment effect in clinical trials
    Brumback, LC
    Pepe, MS
    Alonzo, TA
    [J]. STATISTICS IN MEDICINE, 2006, 25 (04) : 575 - 590
  • [7] Castile R, 2000, PEDIATR PULM, V30, P215, DOI 10.1002/1099-0496(200009)30:3<215::AID-PPUL6>3.0.CO
  • [8] 2-V
  • [9] CHNG K, 2000, PEDIAT PULMONOLOGY, V29, P1
  • [10] *CYST FIBR FDN, 2005, PAT REG 2004 ANN DAT